Endocrinology

Breast Cancer   

Questions discussed in this category



Would you recommend aiming for the postmenopausal range as per the lab reference range or do you have a specific goal?

With studies showing non inferiority to zoledronic acid q 3 months in support of bone metastatic disease, would you consider extrapolating this data a...

Do you look into their stage/risk to decide? Since patients can experience bone loss after stopping denosumab, how do you plan to discontinue?

Would you consider omitting treatment if small tumor and early stage? Or would you use tamoxifen?

Do you extrapolate the results of OPTIMIZE-2 and CALGB 70604 showing that an every 12 week dosing of zolendronic acid is noninferior to ever...


Papers discussed in this category


Lancet,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-07-20

Curr Treat Options Oncol, 2019 Mar 14

J Clin Oncol, 2019 Sep 18

J Clin Oncol, 2022 Jan 18

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-12-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-05-10

The New England journal of medicine, 2018-07-12

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-05-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-04-10

Clinical breast cancer, 2023 Mar 28

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010 Jun 14

Annals of oncology : official journal of the European Society for Medical Oncology, 2022 Mar 14